Lactobacillus helveticus producing antihypertensive di- and...

Details Lactobacillus helveticus producing antihypertensive di- and... Lactobacillus helveticus producing antihypertensive di- and...

2005-05-10

2005-05-10

Tate, Christophet R. (Department: 1651)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Bacteria or actinomycetales

C424S093300, C424S093400, C426S034000, C426S042000, C426S043000, C426S061000, C435S252900

Reexamination Certificate

active

06890529

ABSTRACT:
The invention relates to a new strain,Lactobacillus helveticusLBK-16 H, DSM 13137, and a bacterial preparation containing the same. The new strainLactobacillus helveticusLBK-16 H has proteolytic activity and is capable of promoting the production of nitric oxide, and thus it is useful both as a starter bacterium in dairy industry and as a therapeutic substance as such and in various health-promoting products and pharmaceuticals.

REFERENCES:
patent: 5449661 (1995-09-01), Nakamura et al.
patent: 5541111 (1996-07-01), Yamamoto et al.
patent: 5695796 (1997-12-01), Yamamoto et al.
patent: 5766940 (1998-06-01), Yamamoto et al.
patent: 5854029 (1998-12-01), Yamamoto
patent: 6399140 (2002-06-01), Allen et al.
patent: 6534304 (2003-03-01), Yamamoto et al.
patent: 0 737 690 (1996-10-01), None
patent: 0 821 968 (1999-07-01), None
patent: 1016709 (2000-07-01), None
patent: 2 294 191 (1996-04-01), None
patent: 9916862 (1999-04-01), None
patent: WO 9940798 (1999-08-01), None
patent: WO 200132905 (2001-05-01), None
Catalog of Bacteria and Bacteriophages, 1989, American Type Cultur Collection, 17 th Edition, pp. 177, and 402.*
WPI, Derwent, accession No. 1994-268691, Calpis Shokuhin Kogyo KK: “Prepn. of peptide whichinhibits angiotensin conversion enzyme-by lactic acid bacterium culture of material with specified tri: peptide sequence”; & JP A 6197786, 19940719.
WPI, Derwent, accession No. 1986-110323, Calpis Shokuhin Kogyo KK: “Drug for prophylaxis of hypotension—contains high mol. substance obtd. by removing cell and casein from fermented milk”, & JP 61053216, 19860317.
PAJ/JPO, “Peptide, Angiotensinase Inhibiting Composition and Their Production”, Otsuka Shokuhin KK, &JP 9188694, 19970722.
Anne Pihlanto-Leppala et al; “Angiotensin I Converting Enzyme Inhibitory Peptides Derived from Bovine Milk Proteins”, Int. Dairy Journal, vol 8, 1998, pp. 331.
Yamamoto Naoyuki et al; “Antihypertensive Effect of the Peptides From Casein by an Extracellular Proteinase fromLactobacillus helveticusCP790”, J Dairy Sci., vol. 77, 1994, pp. 917-922.
Korhonen et al, Induction of Nitric Oxide Synthesis by ProbioticLactobacillus rhamnosusGG in J774 Macrophages and Human T84 Intestinal Epithelial Cells, Inflammation, vol. 25, No. 4, Aug. 2001.

Affiliated with

Also associated with

Rating

Lactobacillus helveticus producing antihypertensive di- and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lactobacillus helveticus producing antihypertensive di- and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lactobacillus helveticus producing antihypertensive di- and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3415117